Showing 14,741 - 14,760 results of 46,288 for search '(( 50 ((a decrease) OR (we decrease)) ) OR ( 5 ((step decrease) OR (mean decrease)) ))', query time: 1.43s Refine Results
  1. 14741
  2. 14742
  3. 14743

    NO level in Caco-2 cells after <i>L</i>. <i>acidophilus</i> pretreatment and followed by <i>V</i>. <i>cholerae/ S</i>. <i>sonnei</i>. by Shabnam Zeighamy Alamdary (5345999)

    Published 2018
    “…<p>NO production after 24h, significantly decreased in comparison with <i>V</i>.<i>cholerae/ S</i>. …”
  4. 14744

    Prediction of transition readiness. by Sharon Barak (4803966)

    Published 2025
    “…Forty-two people with DMD or BMD (mean age: 24.3±5.3) participated in this study. The transition domains in which most participants needed help were education and employment (52.5%) and activities of daily living (57.0%). …”
  5. 14745
  6. 14746
  7. 14747
  8. 14748

    FLIM FRET efficiency of: (A) αA-crystallin (B) WT αB-crystallin, their deamidated and domain mutants. by Ekta Tiwary (836674)

    Published 2015
    “…<p>FRET efficiency was calculated from the decrease in life-lime (presented in Fig 8) in 5 to 6 cells. …”
  9. 14749

    Effect of rapamycin (1 ng/ml) and anti-EGFR antibody (5 µg/ml) on reactivity with monoclonal HMB45 in human TSC2<sup>−/−</sup>ASM cells. by Elena Lesma (269724)

    Published 2008
    “…A: Incubation at cell plating time with anti-EGFR for 48 hours decreases markedly the number of cells reacting to HMB45 while the number of negative cells is strongly increased. …”
  10. 14750
  11. 14751
  12. 14752
  13. 14753
  14. 14754

    Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5‑<i>a</i>]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators by Shuai Wang (109515)

    Published 2020
    “…In this work, we reported the structure-based design of triazolo­[1,5-<i>a</i>]­pyrimidines as new ABCB1 modulators, of which <b>WS-691</b> significantly increased sensitization of ABCB1-overexpressed SW620/Ad300 cells to paclitaxel (PTX) (IC<sub>50</sub> = 22.02 nM). …”
  15. 14755

    Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5‑<i>a</i>]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators by Shuai Wang (109515)

    Published 2020
    “…In this work, we reported the structure-based design of triazolo­[1,5-<i>a</i>]­pyrimidines as new ABCB1 modulators, of which <b>WS-691</b> significantly increased sensitization of ABCB1-overexpressed SW620/Ad300 cells to paclitaxel (PTX) (IC<sub>50</sub> = 22.02 nM). …”
  16. 14756

    Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5‑<i>a</i>]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators by Shuai Wang (109515)

    Published 2020
    “…In this work, we reported the structure-based design of triazolo­[1,5-<i>a</i>]­pyrimidines as new ABCB1 modulators, of which <b>WS-691</b> significantly increased sensitization of ABCB1-overexpressed SW620/Ad300 cells to paclitaxel (PTX) (IC<sub>50</sub> = 22.02 nM). …”
  17. 14757

    qRT-PCR analysis of the relative expression levels of TGF-β1, BMP-4 and Smads in embryonic bladders from E12.5 to neonatal day0. by Syed S. Islam (404861)

    Published 2013
    “…Smad4 showed the highest expression pattern from E12.5 to E16.5 and decreased in E18.5 and neonatal day0 <i>(Mann-Whitney test, p<0.005)</i> and <b>D</b>) Inhibitory Smads. …”
  18. 14758
  19. 14759

    DataSheet_2_Immunotherapeutic Effects of Different Doses of Mycobacterium tuberculosis ag85a/b DNA Vaccine Delivered by Electroporation.pdf by Yan Liang (139654)

    Published 2022
    “…</p>Methods<p>Ninety-six female BALB/c mice were challenged with 2×10<sup>4</sup> colony-forming units (CFUs) of MTB H<sub>37</sub>Rv through tail vein injection, then was treated with 10μg, 50μg, 100μg, and 200μg of Mycobacterium tuberculosis (MTB) ag85a/b chimeric DNA vaccine delivered by intramuscular injection (IM) and electroporation (EP), respectively. …”
  20. 14760

    DataSheet_1_Immunotherapeutic Effects of Different Doses of Mycobacterium tuberculosis ag85a/b DNA Vaccine Delivered by Electroporation.pdf by Yan Liang (139654)

    Published 2022
    “…</p>Methods<p>Ninety-six female BALB/c mice were challenged with 2×10<sup>4</sup> colony-forming units (CFUs) of MTB H<sub>37</sub>Rv through tail vein injection, then was treated with 10μg, 50μg, 100μg, and 200μg of Mycobacterium tuberculosis (MTB) ag85a/b chimeric DNA vaccine delivered by intramuscular injection (IM) and electroporation (EP), respectively. …”